Vical Incorporated (VICL) Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
11/2/2012 7:23:17 AM
SAN DIEGO, Nov. 2, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the appointment of Mammen P. "Anza" Mammen, Jr., M.D., as Vice President, Clinical Vaccines. Prior to joining Vical, Dr. Mammen completed a 21-year career in the Army's Medical Corps, retiring as a colonel and recipient of the Legion of Merit. His experiences have spanned the areas of clinical medicine, infectious disease research, medical diplomacy, clinical trials, vaccine program management, and public health.
comments powered by